PSA Bounce and Biochemical Failure After Brachytherapy for Prostate Cancer: A Study of 820 Patients With a Minimum of 3 Years of Follow-Up
- 1 July 2011
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 80 (3), 735-741
- https://doi.org/10.1016/j.ijrobp.2010.02.021
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Prostate-specific Antigen Bounce After Prostate Brachytherapy: Review of a Confusing PhenomenonUrology, 2009
- PSA Kinetics and PSA Bounce Following Permanent Seed Prostate BrachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus ConferenceInternational Journal of Radiation Oncology*Biology*Physics, 2006
- PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling timeInternational Journal of Radiation Oncology*Biology*Physics, 2005
- A retrospective comparison of androgen deprivation (AD) vs. no AD among low-risk and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomyInternational Journal of Radiation Oncology*Biology*Physics, 2004
- An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow‐upCancer, 2002
- PROSTATE SPECIFIC ANTIGEN BOUNCE AFTER RADIOACTIVE SEED IMPLANTATION FOLLOWED BY EXTERNAL BEAM RADIATION FOR PROSTATE CANCERJournal of Urology, 2000
- The american brachytherapy society recommendations for permanent prostate brachytherapy postimplant dosimetric analysisInternational Journal of Radiation Oncology*Biology*Physics, 2000
- American brachytherapy society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Physiological Variation of Serum Prostate Specific Antigen in the 4.0 to 10.0 ng./ml. Range in Male VolunteersJournal of Urology, 1996